期刊文献+

VEGF表达与鼻咽癌血管生成、瘤细胞增殖及预后的关系 被引量:2

Relationship between expression of VEGF with angiogenesis,tumor cell proliferation and prognosis in nasopharyngeal carcinoma
下载PDF
导出
摘要 目的探讨血管内皮生长因子(VEGF)表达与鼻咽癌(NPC)血管生成、肿瘤细胞增殖及预后的关系。方法选取有明确病理诊断、临床资料完整并随访5 a以上的86例NPC患者活检标本,采用免疫组织化学技术检测活检标本中VEGF、微血管密度(iMVD)和增殖细胞核抗原(PCNA)的表达,并分析其与临床病理及预后的关系。结果全组VEGF阳性表达率69.9%(60/86),与iMVD、PCNA呈显著正相关,与组织学分级、原发灶范围、淋巴结转移、临床分期及生存期亦具相关性。结论NPC组织中VEGF过表达可能参与NPC发生发展,可作为判断NPC恶性程度、侵袭能力和预后的指标。 Objective To evaluate the expression of vascular endothelial growth factor (VEGF) and its relationship with tumor cell proliferation and prognosis in nasopharyngeal carcinoma (NPC). Methods The expression of VEGF, intratumoral microvascular density (iMVD) and tumor cell proliferation (PCNA) was measured with immunohistochemieal method in NPC patients followed up over 5 years. Results Positive expression rate of VEGF was 69.9% (60/86). VEGF expression was positively correlated with iMVD and PCNA, and also correlated with the tumor pathological grade, extent of primary lesion, lymph node metastasis, clinical stage and survival time. Conclusion VEGF plays an important role of prognosis in NPC through regulation of angiogenesis and tumor cell proliferation.
出处 《山东医药》 CAS 北大核心 2009年第44期15-17,共3页 Shandong Medical Journal
基金 湖北省卫生厅科研一般项目(JX4B52)。
关键词 鼻咽肿瘤 血管内皮生长因子 血管生成 预后 nasopharyngeal neoplasms vascular endothelial growth factor angiogenesis prognosis
  • 相关文献

参考文献8

  • 1Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors [ J ]. Breast Cancer Res Treat, 1995,36 (2) : 169-180.
  • 2Rini BI, Small EJ. Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma [ J ]. J Clin Oncol, 2005,23 (5) : 1028-1043.
  • 3Levy AP, Lery NS, Loscalzo J, et al. Regulation of vascular endothelial growth factor in cardiac myocytes [J]. Circ Res, 1995,76 (5) :758-766.
  • 4Krishna SM, James S, Balaram P. Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status [ J]. Virus Research, 2006,115 ( 1 ) :85-90.
  • 5Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications [ J ]. Semin Oncol, 2002,29 (16) : 10-14.
  • 6Murono S, Inoue H, Tanabe T, et al. Induction of cyclooxygenase- 2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma [ J ]. Proc Natl Acad Sic USA, 2001,98 (12) :6905-6910.
  • 7Kushlinskii NE, Orinovskii MB, Gurcvieh LE, et al. Expression of biomolecular maekers (Ki-67, PCNA, Bcl-2, BAX, BclX, VEGF) in breast tumors [J]. Bull Exp Biol Med, 2004,137(2) :182-185.
  • 8王天宝,吴小鹏,张维东,李兆亭.重组人内皮抑素对裸鼠胃癌瘤株生长的影响[J].中国普通外科杂志,2004,13(4):268-271. 被引量:12

二级参考文献11

  • 1O'Reilly MS, Boehm T, Shing Y, et al. Endostatin : An endogenous inhibitor of angiogenesis and human tumor growth[J].Cell,1997,88(2) :277 -285.
  • 2Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistence[Jl. Nature, 1997, 390(6658): 404-407.
  • 3Yamanaka B, Zullo SA, Ramsey J, et al. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus[ J]. Cancer Gene Ther, 2001 , 8(10) : 796-802.
  • 4Bertolini F, Fusetti L, Mancuso P, e t al. Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma [ J ]. Blood, 2000, 96(1) :282 -287.
  • 5Tai KF, Chen PJ, Chen DS, et al. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors[J]. J Gene Med, 2003,5(5) :386 -98.
  • 6Nyberg P, Heikkila P, Sorsa T, et al. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13 [ J ] . J Biol Chem, 2003 ,278(25) :22404 -22411.
  • 7Pulkkanen KJ, Laukkanen JM, Fuxe J, et al. The combination of HSV- tk and endostatin gene therapy eradicates orthotopie human renal cell carcinomas in nude mice [ J ]. Cancer Gene Ther. 2002.9(11) :908 -916.
  • 8李文,朱美财,王荫静,占志,刘成刚,向培德.人内皮抑素克隆表达及对血管内皮细胞生长的抑制作用[J].中华微生物学和免疫学杂志,2000,20(5):402-404. 被引量:3
  • 9孙惠川,汤钊猷,王鲁,高冬梅,薛琼,李晓明,陈军.Endostatin抑制裸鼠移植性肝癌切除后的复发转移[J].中华肿瘤杂志,2000,22(6):469-470. 被引量:6
  • 10刘江秋,李忠义,陈林生,孙亦红,徐璐,汪军远,刘万兴,夏结来.重组人血管内皮抑制素抗肿瘤效应的应用研究[J].细胞与分子免疫学杂志,2001,17(1):63-64. 被引量:15

共引文献11

同被引文献30

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部